InsidersTradesSigma
Follow the Intergrum AB share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Intergrum AB has published 2 insider filings. Market capitalisation: €215.5m. The latest transaction was filed on 3 September 2026 (Purchase). Among the most active insiders: Per Nilsson. The full history is openly available.
2
Insider Decl.
n/a
Thresholds
€31,734
2 ops.
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
Fundamental score
Ranked 26,370 of 29,062 companies
21.1
score / 100
Value9
Quality33
FCF yld-27%
Earn yld-22%
EV/EBITDA·
ROE-27%
Gross mgn69%
Net mgn-51%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
Declarations2 total
5,000 shares@ SEK 9.41AktieISIN SE0009807266FI:csv-185be15ea2c792abd478
29,002 shares@ €0.94790.14% mcap100.0% of flowAktieISIN SE0009807266FI:A003U537-1
2 of 2 declarations
About Intergrum AB
Intergrum AB is a healthcare and pharmaceutical company listed on the Stockholm Stock Exchange. It focuses on developing innovative solutions to enhance healthcare.